Going on the offensive: Shiseido to invest over $75m in brand equity and employee training

By Amanda Lim

- Last updated on GMT

Shiseido is planning to invest JPY10bn in both brand equity and its employees. [Shiseido]
Shiseido is planning to invest JPY10bn in both brand equity and its employees. [Shiseido]

Related tags Shiseido Business Japan

Japanese beauty major Shiseido is planning to invest JPY10bn (USD75.5m) in both brand equity and its employees as part of plans to go on the offensive and buck the declining trend of the market.

During the firm’s first-half earnings conference held on August 10, Shiseido president and CEO Masahiko Uotani reflected upon the tough decisions the firm has made against the turbulence wrought by COVID-19.

Some of the decisions included selling off its personal care division, as well as several brands such as Laura Mercier and bareMinerals.

“We have undertaken transformation globally in earnest that required tough decisions and thoroughly reviewed poor and unprofitable businesses. At the same time, to defend and secure profits for every fiscal year while sales were on a declining trend, we implemented agile cost management including marketing cost reductions in line with sales decline,” ​said Uotani.

However, he expressed that the firm has to shift its stance and push itself to take a more “offensive”​ approach to ensure growth moving forward.

“However, after three years of this situation, further continuation of this approach I think will lead to a downward trend. I strongly feel a sense of crisis. Therefore, I think it's necessary to stop that trend and transform our management to be offensive by increasing strategic investment.”

Strengthening a brand and its people

Uotani said it was imperative for the firm to strengthen its brand equity, therefore, the firm is set to invest an additional JPY5bn (USD37.8m) this year to do so.

“Top priority in our strategy… is to strengthen brand equity which serves as a basis for our bond with consumers and for continuous purchases of our products by consumers,”​ Uotani said.

He elaborated that the firm would leverage its strengths in research and development, which is becoming increasingly important for the post-pandemic consumer.

“After experiencing COVID-19, there is a growing awareness among consumers in the world toward health and immunity, efficacy and functions of cosmetics, science, and formulation technologies to support product development. We will proactively communicate such information like benefits and brand equity through advertising and the like, as important factors backing credibility of brand equity.”

The company will also reel back on price-orientated promotions, which can dilute brand equity.

“We need to shift our investment to strengthen brand equity and shift away from over-emphasis on promotions,”​ said Uotani.

Another JPY5bn (USD37.8m) will be invested in its people, Shiseido’s “biggest assets”,​ said Uotani.

“There is a sense of stagnation in the society and also a cooped up feeling among our people due to COVID-19 pandemic as the industry has been impacted quite seriously. To overcome this situation, strengthening investment into people capital and improving employee engagement are very important strategies.”

This would involve its digital academy, which re-trains and re-skills its employees to adapt to today’s digital landscape. Furthermore, the firm plans to build a global training centre in Tokyo.

The initial JYP10bn (USD75.5m) investment will not be a one-off, Uotani assured and will continue beyond 2022.

“We will make efforts companywide and review our business in response to changes in the market environment to achieve reduction targets for COGS and SG&A ratios, aiming at achieving an operating profit margin of 15%.”

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us


View more


Beauty 4.0 Podcast